Find Academic Supervisors

Anton WutzView profile

Professor

• Epigenetics
• X chromosome inactivation
• Stem cell differentiation
• +6 more

Anton Wutz is a Full Professor of Genetics at the Institute of Molecular Health Sciences within the Department of Biology at ETH Zurich. His research focuses on epigenetic regulation and cell identity control, particularly examining how the cell nucleus specifies different cell types in the body and how changes in cell identity are regulated during development. His educational background includes: PhD from Technical University of Graz (1997), with research conducted at the Research Institute of Molecular Pathology in Vienna, Austria Postdoctoral work with Rudolf Jaenisch at the Whitehead Institute for Biomedical Research in Cambridge, USA Group leader at the Research Institute of Molecular Pathology (2001-2009) Principal Investigator at the Wellcome Trust Centre for Stem Cell Research, University of Cambridge (2009-2013) Professor Wutz's research primarily investigates epigenetic mechanisms, with a particular focus on X chromosome inactivation and its role in development and disease. His laboratory has made significant contributions to understanding how chromatin architecture and nuclear organization regulate gene expression during cell differentiation. The group has pioneered the use of haploid embryonic stem cells for genetic screening approaches, enabling novel insights into epigenetic regulation. Their work bridges molecular biology, genetics, and developmental biology to uncover fundamental principles of cellular identity specification. Analysis of Professor Wutz's recent publications reveals a strong focus on X chromosome inactivation mechanisms, with particular attention to the Xist RNA and its associated protein complexes. His research spans multiple model systems including mouse embryonic stem cells, organoids, and in vitro gametogenesis models. Key themes include the role of phase separation in chromatin organization, the impact of chromosome dosage on cellular processes, and the connection between epigenetic regulation and disease mechanisms such as autoimmunity. His laboratory continues to develop innovative genetic tools for studying mammalian developmental pathways. Professor Wutz actively contributes to several educational programs at ETH Zurich, teaching courses in epigenetics, computational methods in genome analysis, and fundamental biology. His laboratory serves as a training ground for PhD students and postdoctoral researchers interested in epigenetics and developmental biology. Through collaborations with other research groups at ETH Zurich and internationally, his team maintains a strong research program exploring the fundamental mechanisms of epigenetic regulation. The Wutz laboratory operates within the Institute of Molecular Health Sciences at ETH Zurich, utilizing advanced molecular and cellular techniques to investigate epigenetic mechanisms. The group maintains active collaborations with other research teams both within ETH Zurich and internationally, fostering a dynamic research environment focused on understanding the molecular basis of cell identity regulation.

Xiaojun TianView profile

Associate Professor

• Systems Biology
• Synthetic Biology
• Nonlinear Dynamics
• +5 more

Xiaojun Tian is an Associate Professor at Arizona State University's School of Biological and Health Systems Engineering. He leads the Tian Laboratory, which focuses on quantitative approaches to understanding biological systems through the integration of mathematical modeling and experimental techniques. His work bridges systems biology, synthetic biology, and biomedical engineering. Education: Ph.D. in Systems Biology from Nanjing University (2012) Postdoctoral Fellow at Virginia Tech (2012-2014) Postdoctoral Fellow at University of Pittsburgh (2014-2017) Research Interests: Dr. Tian's research spans multiple interdisciplinary areas at the intersection of biology, engineering, and mathematics. His laboratory employs quantitative experiments and mathematical modeling to investigate fundamental problems in systems and synthetic biology, with particular focus on gene circuits, nonlinear dynamics, and cellular decision-making processes. His work on epithelial-mesenchymal transition (EMT) has provided important insights into cancer metastasis and tissue development. The lab's approach combines theoretical frameworks with experimental validation to develop predictive models of biological behavior. Research Trends: Analysis of Dr. Tian's recent publications reveals a strong focus on resource competition in synthetic gene circuits, growth feedback mechanisms, and the development of robust control strategies for biological systems. His work increasingly integrates concepts from nonlinear dynamics, control theory, and systems biology to address challenges in synthetic biology engineering. Recent publications demonstrate a shift toward more complex multi-module circuit designs and the development of strategies to mitigate context-dependent circuit failures. Scientific Awards: NIH Maximizing Investigators' Research Award (MIRA) NSF Career Award Advising and Grants: Dr. Tian has successfully mentored graduate students including Diego Barra Avila (who successfully defended his Master's Thesis) and Hanah (who passed her comprehensive exam). His research is supported by multiple significant grants including an NIH grant titled "Multi-Scale Engineering of Heterogeneity in the Host-Aware Synthetic Gene Circuits" (2021-2026), an NSF grant on "Epigenetics Control by Noncoding RNA" (2019-2022), and an NSF CAREER award "Molecular and Cellular Mechanisms Underlying Circuit-Host Interactions" (2022-2027). Laboratory: The Tian Laboratory at ASU focuses on developing quantitative approaches to understand and engineer biological systems. The lab actively recruits talented and motivated graduate students interested in interdisciplinary research at the interface of biology, engineering, and mathematics. Current research directions include investigating circuit-host interactions, developing strategies to address resource competition in synthetic gene circuits, and understanding the dynamical mechanisms underlying cellular decision-making processes.

• Soft Condensed Matter
• Experimental Biophysics
• Origin of Life
• +4 more

Dr. Vahid Nasirimarekani is a group leader at the Laboratory for Fluid Physics, Pattern Formation and Biocomplexity (LFPB) within the Max Planck Institute for Dynamics and Self-Organization. He focuses on experimental studies of soft condensed matter , self-organization in biological systems , and the physical principles underlying the origin of life .

Wilfried WeberView profile

Professor

• Synthetic Biology
• Biohybrid Materials
• Optogenetics
• +3 more

Wilfried Weber is a leading academic in synthetic biology and biomaterials, currently serving as Scientific Director of the Leibniz Institute for New Materials (INM) and Professor (W3) for New Materials at Saarland University since 2023. Previously, he was Founding Scientific Director of CIBSS and Full Professor of Synthetic Biology at the University of Freiburg (2009–2023). His career spans roles as a Group Leader at ETH Zurich (2006–2009) and co-founder of BioVersys AG (2008). Research Focus: Interdisciplinary work at the intersection of synthetic biology and biomaterials, emphasizing optogenetic tools, CRISPR/Cas integration, and dynamic biohybrid circuits. Education: Diplôme d’Ingénieur en Biotechnologie (Strasbourg, 2000), PhD in Biotechnology (ETH Zurich, 2003–2005). His research interests include: Programmable biomaterials with synthetic biological components Optogenetic control of cellular processes CRISPR/Cas-based diagnostics and therapeutic delivery Dynamic gene expression systems with environmental responsiveness Recent publications highlight trends in biohybrid materials (2024–2025) for RNA detection and transcriptional control, alongside optogenetic receptor activation (2024) and redox biosensors (2023). His work bridges molecular design, material properties, and clinical translation. As Scientific Director of INM and CIBSS, he leads teams integrating synthetic biology with materials science, driving innovations in adaptive prototissues, therapeutic cell engineering, and noninvasive signaling tools.

Gregory A. VothView profile

Professor

• Biophysics
• Materials Chemistry
• Theoretical Chemistry
• +5 more

Gregory A. Voth serves as Haig P. Papazian Distinguished Service Professor in the Department of Chemistry at the University of Chicago, where he leads a highly productive research group focused on theoretical and computational approaches to complex biophysical and chemical systems. His work bridges multiple disciplines through innovative methodology development. Dr. Voth's research program centers on: Developing multiscale theoretical frameworks connecting quantum to classical mechanics Creating advanced coarse-graining techniques for biomolecular and materials systems Simulating charge transport phenomena in biological and synthetic systems Modeling viral infection mechanisms with atomic-level detail His group has pioneered computational approaches that reveal fundamental mechanisms in biological processes, most notably how HIV capsids exploit electrostatic ratcheting to enter cell nuclei. The Voth Group has also created the first comprehensive computational model of the entire SARS-CoV-2 virus. Recent methodological advances include entropy-based coarse-graining, machine learning integration with statistical mechanics, and the RAPTOR software package for proton transport simulations. Dr. Voth's scientific impact is recognized through numerous prestigious awards including the 2025 ACS Award in Theoretical Chemistry, the S F Boys-A Rahman Award (2019), and a Festschrift in The Journal of Physical Chemistry B celebrating his 65th birthday. His research is consistently funded by NIH and NSF, supporting a vibrant group of students and postdocs who regularly receive competitive fellowships and awards. Through extensive collaborations with experimental groups worldwide, Dr. Voth's theoretical work provides critical insights that guide experimental design and interpretation across virology, biophysics, and materials science.

• Biomedical Science
• Cancer Biology
• RNA Biology
• +3 more

Dr. Chinedu Anene is a Senior Lecturer at the School of Health, Leeds Beckett University, with a research focus on biomedical science. He is affiliated with the Centre for Biomedical Science Research, contributing to fields such as cancer biology, RNA regulation, and tumor microenvironment studies. His research spans molecular oncology, including metastasis mechanisms in melanoma and esophageal squamous cell carcinoma, RNA biology involving enhancer RNAs and RNA-binding proteins, and cellular signaling pathways like the Hippo pathway in cervical cancer. His recent work explores viral RNA processing, platelet-derived extracellular vesicles in cancer progression, and transcriptomic biomarkers for prognosis. Publications highlight interdisciplinary approaches combining genomics, bioinformatics, and clinical applications. Key themes include noncoding RNA interactions, miRNA profiling in diabetes-related breast cancer, and host-virus dynamics.

• Biophysics
• Computational Physics
• Statistical Mechanics
• +7 more

Enrico Carlon is a Professor at KU Leuven within the Faculty of Sciences and the Department of Physics and Astronomy . He leads the Statistical and Computational Physics research group in the Physics of Soft Matter and Biophysics unit, part of the Physics of Life (PoL@KUL) cluster. Research Focus: DNA mechanics , chromatin structure , biomolecular condensates , and SMC protein dynamics Teaching: Advanced Statistical Mechanics, Computational Physics (Molecular Dynamics/Monte Carlo), Polymer Physics Research Interests center on understanding DNA's mechanical behavior under cellular conditions, including DNA elasticity across length scales Non-local twistable wormlike chain modeling Entropic DNA pistons for active transport Chromatin microphase separation SMC-mediated loop extrusion mechanics DNA-mediated allostery mechanisms His article trends emphasize computational modeling of DNA's statistical mechanics, with recent work on topological domain analysis , coarse-grained DNA simulations , and chromatin structure inference from microscopy data. Scientific Awards : 2024 Editor's Pick for 'Insights into elastic properties of coarse-grained DNA models' 2025 Editors' Suggestion for 'Statistical mechanics of multiplectoneme phases in DNA' Selected for special issue on 'Chromatin Structure and Dynamics' (2025) Advising includes PhD students Lucas Dooms , Arianna Fassino , Eva Punter , and Midas Segers , plus master students like Fritz Förster (TU Dresden collaboration). His lab develops computational approaches within the Physics of Life cluster, collaborating with international groups on DNA's role in nanopore proteomics and chromosome organization .

Jörg GsponerView profile

Professor

• Computational Biochemistry
• Protein Interactions
• Intrinsically Disordered Proteins
• +5 more

Dr. Jörg Gsponer is Professor and Head of the Department of Biochemistry & Molecular Biology at the University of British Columbia's Faculty of Medicine, with a joint appointment at the Michael Smith Laboratories in the Faculty of Science. Appointed as Department Head in November 2024 after serving as interim Head since February 2024, he has been at UBC since 2009 and was promoted to Professor in 2021. Dr. Gsponer holds a dual degree in medicine and theoretical biophysics through the Swiss MD-PhD program. His educational background includes an MD from the University of Lausanne (1997), a PhD in Biochemistry from the University of Zurich (2002), post-doctoral training at the University of Cambridge Chemistry Department (2003), and MRC Research Fellow at the Laboratory of Molecular Biology in Cambridge (2006). His research focuses on intrinsically disordered proteins (IDPs) and their connections to cancer and neurodegeneration. Using advanced computational methods, molecular modeling, simulations, and bioinformatics approaches, his lab explores how protein structure and interactions contribute to cellular phenotypes. Recent work has incorporated generative AI tools like AlphaFold to advance protein biochemistry research. The lab has developed several computational tools including MoRFchibi, GraPES, and LIST for predicting protein features and interactions. Dr. Gsponer's research has resulted in numerous high-impact publications, particularly in areas of protein-protein interactions, intrinsically disordered regions, and computational approaches to understanding disease mechanisms. His work shows strong trends toward integrating AI with traditional biochemical approaches to solve complex problems in protein science. Michael Smith Foundation for Health Research Career Investigator Distinguished Achievement Award for Overall Excellence from UBC Faculty of Medicine As Department Head, Dr. Gsponer emphasizes team leadership and delegation, working with an executive team to advance scientific knowledge and innovate in training the next generation of scientists. He has spearheaded initiatives in data science teaching and recruitment in generative AI and nanomedicine. His lab continues to secure research funding for projects exploring protein interactions in disease contexts, with particular focus on cancer and neurodegenerative disorders. The Gsponer Lab maintains strong collaborations across multiple disciplines and institutions, operating within the Centre for High-Throughput Biology (CHiBi) at the Michael Smith Laboratories. The lab environment fosters interdisciplinary research combining computational approaches with experimental validation to address fundamental questions in protein science.

Stirling ChurchmanView profile

Professor

• Gene expression regulation
• Transcription
• RNA processing
• +6 more

Stirling Churchman, Ph.D., is Professor of Genetics at Harvard Medical School and leads the Churchman Lab within the Blavatnik Institute. Her work integrates experimental and computational approaches to dissect the multiple layers of gene regulation, spanning transcription, RNA processing, and translation in both nuclear and mitochondrial systems. Education: While specific degrees are not detailed in the provided text, Dr. Churchman’s extensive publication record and faculty position at Harvard Medical School indicate advanced graduate and postdoctoral training in molecular biology and genomics. Research Interests: Nascent RNA dynamics: Using NET-seq and nanopore direct RNA sequencing to capture transcription and co-transcriptional processing at single-nucleotide resolution. Mitochondrial gene expression: Investigating how mitochondrial transcription and translation are synchronized with nuclear programs to maintain respiratory chain homeostasis. Chromatin architecture & single-molecule genomics: Employing Fiber-seq to visualize RNA polymerases and chromatin structure along native DNA fibers up to 30 kb in length. Post-transcriptional splicing kinetics: Quantifying intron removal dynamics in living cells to understand fidelity and timing of mRNA maturation. Across more than 60 publications (2011-2025), a clear trend emerges: Dr. Churchman develops cutting-edge sequencing technologies and applies them to fundamental questions in gene expression. Recent work (2024-2025) highlights a shift toward mitochondrial biology, antibiotic action on mitoribosomes, and the global quantification of RNA flow across cellular compartments. Scientific Awards & Honors: Specific named awards are not listed in the provided text; however, her continuous funding, high-impact publications, and professorial appointment at Harvard Medical School reflect significant peer recognition. Laboratory & Team: The Churchman Lab is located in the New Research Building at Harvard Medical School (Blavatnik Institute, Room 356). The team is interdisciplinary, combining expertise in biology, physics, chemistry, and computation to pursue integrative studies of gene regulation. Funding & Grants: While explicit grant numbers are not provided, the sustained productivity, large team, and resource-intensive technologies (e.g., nanopore sequencing, cryo-EM collaborations) indicate substantial and ongoing extramural funding from NIH and other agencies.

• Bioinformatics
• Computational Biology
• RNA Biology
• +5 more

Chao Zeng is an Associate Professor at Waseda University’s Research Institute for Science and Engineering, affiliated with the School of Advanced Science and Engineering. He holds a PhD in Science from the University of Tokyo (2016) and a Master’s in Information Science from Kyoto University (2013). His research integrates computational biology and RNA genomics, focusing on non-coding RNAs, RNA localization mechanisms, and repetitive genetic elements. Dr. Zeng’s work spans bioinformatics algorithm development , RNA structure-function relationships , and transcriptomic regulation in disease . Key interests include lncRNA interactions with ribosomes, phase separation of RNA, and RNA-binding protein networks. His lab employs high-throughput sequencing, machine learning, and comparative genomics to decode RNA regulatory systems across species. His publications emphasize RNA biology in cancer and fibrosis , with recent work exploring mitotic RNA editing, inflammatory recovery pathways, and RNA quality control. Article analyses reveal consistent themes: lncRNA mechanisms (35%), RNA-protein interactions (25%), computational methods (20%), splicing/localization (15%), and translational applications (5%). Awards & Grants: Waseda University Teaching Award (2022) JSPS Grants: PI for ‘Repetitive Elements in Genome Regulation’ (2022-2025) and ‘lncRNAs in Genetic Compensation’ (2020-2022) Co-investigator for Phase Separation Research (2023-2026) and Cancer RNA Mechanisms (2021-2023) He leads the RNA Bioinformatics group at Waseda, collaborating with the Hamada Lab and international teams. Future work targets RNA-based therapeutics and multi-omics integration for disease modeling.

Carl C. CorrellView profile

Associate Professor

• Ribosome Biogenesis
• RNA-Protein Interactions
• Cancer Therapeutics
• +3 more

Dr. Carl C. Correll serves as Associate Professor in the Department of Biochemistry and Molecular Biology at Rosalind Franklin University's Chicago Medical School, with dual appointments in the School of Graduate and Postdoctoral Studies and the Center for Proteomics and Molecular Therapeutics. His research centers on ribosome biogenesis mechanisms, specifically the dynamic RNA-protein interactions governing pre-ribosomal assembly. The lab investigates how the DEAH helicase Dhr1 dislodges U3 snoRNA from pre-ribosomes—a process critical for ribosome maturation and emerging as a cancer therapeutic target—and how regulators like Utp14 control Dhr1 activity. These studies combine biochemical, genetic, and structural approaches to unravel fundamental cellular processes. Dr. Correll's publication record spans two decades with consistent output in high-impact journals including PLOS Biology, Molecular and Cellular Biology, and Nature Structural & Molecular Biology. His work shows a clear trajectory from structural RNA biochemistry (early 2000s) toward mechanistic dissection of ribosome assembly factors, with increasing focus on cancer-relevant pathways since 2015. Scientific recognition includes: American Cancer Society Postdoctoral Fellowship Dr. Correll mentors PhD students and postdocs, with alumni securing positions at Scripps Florida, Winthrop University, and industry roles. Current projects examine Dhr1 regulation by Utp14 and Imp3/Imp4 control by Mpp10, supported through institutional resources and collaborations with Dr. Johnson's lab at UT Austin. The lab operates within Rosalind Franklin's Center for Proteomics and Molecular Therapeutics, providing access to advanced biochemical and molecular facilities for studying RNA-protein dynamics with direct implications for ribosomopathy-related diseases.

Mirek DundrView profile

Associate Professor

• Nuclear Organization
• Genome Architecture
• RNA Processing
• +5 more

Mirek Dundr, PhD, serves as Associate Professor in the Department of Cell Biology and Anatomy at Rosalind Franklin University's Chicago Medical School. He is actively affiliated with the Center for Cancer Cell Biology, Immunology, and Infection Research, where his laboratory investigates fundamental mechanisms of nuclear organization. Dr. Dundr's research centers on membraneless biomolecular condensates formed through liquid-liquid phase separation, with particular focus on Cajal bodies in cancer cells. His groundbreaking work demonstrates that these structures physically interact with multiple chromosomes to form specialized gene clusters absent in healthy cells, directly linking 3D genome architecture to cancer pathology. Using advanced spectral imaging and genomic techniques, his lab revealed how chromosome 1 reorganizes into rosette structures around Cajal bodies, and how depletion of these bodies disrupts RNA processing and gene activity. This research establishes nuclear compartmentalization as a critical factor in cancer cell function. His publication record shows consistent high-impact output in journals including Nature Communications , Trends in Biochemical Sciences , and Cells , with recent work emphasizing phase separation principles in nuclear organization. Dr. Dundr's research program integrates molecular biology, advanced microscopy, and genomic approaches to address fundamental questions about nuclear architecture. Prospective students in Dr. Dundr's lab gain expertise in cutting-edge techniques for studying nuclear dynamics, including deep imaging analysis, 4C-seq mapping, and molecular perturbation assays. The lab emphasizes interdisciplinary training at the intersection of cell biology and biophysics, with opportunities for collaboration through the university's Center for Cancer Cell Biology. His research program continues to explore how phase-separated nuclear compartments regulate gene expression and contribute to disease mechanisms.

• RAF Kinase Signaling
• Inflammatory Response Regulation
• Cancer Biology
• +3 more

Manuela Baccarini is a Professor at the University of Vienna and serves as Vice Rector within the Rectorate. She is affiliated with the Department of Microbiology, Immunobiology and Genetics, where her research focuses on RAF kinase signaling, cell proliferation, and molecular mechanisms in cancer and inflammatory responses. Her recent work explores autophagy, lysosomal trafficking, and signal transduction dynamics. Email: manuela.baccarini@univie.ac.at Research Areas: RAF kinase, cell signaling, cancer biology, autophagy, inflammation Recent Research Trends: Her publications from 2018–2025 highlight RAF kinase's role in autophagic lysosome reformation, inflammatory gene regulation via RNA decay, endothelial cell mechanics, and metabolic targeting in tumors. The work spans cancer biology, immunology, and molecular genetics. Teaching: She supervises seminars in the Vienna Biocenter PhD Program and courses on cellular architecture and maintenance.

Joshua LequieuView profile

Assistant Professor

• Computational Materials Science
• Soft Matter
• Biomaterials
• +4 more

Joshua Lequieu is an Assistant Professor in the Department of Chemical and Biological Engineering at Drexel University. His research focuses on developing predictive multi-scale models of nano-structured soft matter, bridging atomistic, coarse-grained, and field-theoretic simulations to address challenges in materials science and biological systems. He holds a Ph.D. in Molecular Engineering from the University of Chicago (2017), an M.S. in Chemical Engineering from the University of Wisconsin-Madison (2013), and a B.S. in Chemical Engineering from Cornell University (2010). Education : Ph.D., Molecular Engineering, University of Chicago (2017) M.S., Chemical Engineering, University of Wisconsin-Madison (2013) B.S., Chemical Engineering, Cornell University (2010) Dr. Lequieu’s research spans block polymer self-assembly, nanoporous materials, and chromatin structure prediction. His lab develops novel simulation techniques combining field-theoretic and molecular dynamics methods to model polymer systems across length scales, with applications in energy, human health, and advanced materials. Recent work explores molecular chirality and non-equilibrium processing for expanding block copolymer phase diversity. Scientific trends in his publications include multi-scale modeling of soft materials, computational approaches for chromatin organization, and simulation algorithm development. His 2025 articles on AB2 star polymers and Bayesian optimization highlight these themes. Scientific Awards : NSF CAREER Award (2024) Charles E. Kaufman Foundation New Investigator Award (2021) Edward J. Kramer Prize in Materials (2019) William Rainey Harper Dissertation Fellowship (2017) Genentech George Scheele Award (2008) Dr. Lequieu advises graduate students in chemical engineering and biological materials, with a lab actively pursuing computational tool development for field-theoretic simulations (OpenFTS) and chromatin modeling. His group has secured grants including the NSF CAREER award to advance chemically specific polymer models. The Lequieu Lab generates open-source simulation software (OpenFTS, fieldkit) and maintains active collaborations in computational materials science and chromatin biology.

Stefan KubicekView profile

Researcher

• Chemical Epigenetics
• Chromatin Biology
• Cancer Biology
• +5 more

Stefan Kubicek is a Principal Investigator and Head of the Molecular Discovery Platform at CeMM (Center for Molecular Medicine of the Austrian Academy of Sciences). His research bridges Chemical Biology and Epigenetics , focusing on small molecules that alter cellular identity through chromatin pathways and nuclear metabolism. Previously, he led the Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, a public-private partnership with Boehringer Ingelheim and Haplogen. MSc in Synthetic Organic Chemistry (Vienna University of Technology) PhD in Molecular Biology (Thomas Jenuwein Lab, IMP Vienna) Postdoc in Chemical Biology (Stuart Schreiber, Broad Institute) His work explores ATP-dependent chromatin remodeling in cancer and diabetes, developing chemical tools against epigenetic modifiers. Recent publications highlight nuclear metabolic targets , protein phase separation , and pancreatic cell transdifferentiation . Collaborations with pharmaceutical companies have yielded high-impact studies, including Nature Genetics (2019) on synthetic lethal cancer targets. Research Funding includes: ERC Proof of Concept Grant (ONCO-SPLICE, 2024-2026) FWF Stand-Alone Program (2024-2027) WWTF Life Sciences Grant (2022-2025) Breakthrough T1D Award (2024-2025) Lab members include Predoctoral Fellows (Sandra Goll, Andreas Reicher, Jamie Reilly, Jiri Reinis, Jonathan Shklarek), Postdoctoral Fellows (Tuan-Anh Nguyen), and technicians (Maria Ciobanu, Diana Daum). His team deploys high-throughput screening , genetic code expansion , and stochastic protein tagging to uncover nuclear metabolic-epigenetic connections.